Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Francisco Morandeira-Rego"'
Autor:
Lorena Rodríguez-Alonso, Francisco Rodríguez-Moranta, Jordi Bas Minguet, Eugènia Santacana Juncosa, Jordi Guardiola, Francisco Morandeira Rego, Helena Colom Codina, Núria Padullés Zamora, Ariadna Padullés Zamora, Katja Serra Nilsson
Publikováno v:
British Journal of Clinical Pharmacology. 87:494-505
Therapeutic drug monitoring of infliximab can guide clinical decisions in patients with loss of response and in those who can benefit from a de-intensification. The aim of this study was to determine the impact of therapeutic drug monitoring combined
Autor:
Elena Álvarez de la Campa, Marina Garcia-Prat, Andrea Martín-Nalda, Pere Soler-Palacín, Roger Colobran, Xavier de la Cruz, Clara Franco-Jarava, Manuel Hernández-González, Francisco Morandeira-Rego, Xavier Solanich, Virgínia Mas-Bosch
Publikováno v:
Journal of Clinical Immunology. 37:781-789
The complement system is an important effector arm of innate immunity and plays a crucial role in the defense against common pathogens. But effective defense and maintenance of homeostasis requires a careful balance between complement activation and
Autor:
Joan Torras Ambros, Juliana Draibe, Francisco Morandeira-Rego, Josep Maria Cruzado Garrit, Laura Martinez Valenzuela, Xavier Fulladosa Oliveras, Sergio Navarro Velazquez
Publikováno v:
Rheumatology. 58
Autor:
Mariona Mestre Playa, Esmeralda de la Banda Ledrado, Francisco Morandeira Rego, Victoria Clapés Puig, Josep Sarrà Escarré, Enric Gamundí Grimalt
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 55:e37-e40
Autor:
Ferran Llopis, Carolina Garcia-Vidal, Mariona Mestre, Jordi Dorca, Diego Viasus, Francisco Morandeira-Rego, Antonella F. Simonetti, Jordi Carratalà
Publikováno v:
BMJ Open
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Objectives It has been suggested that statins have an effect on the modulation of the cytokine cascade and on the outcome of patients with community-acquired pneumonia (CAP). The aim of this prospective, randomised, double-blind, placebo-controlled t